21
Participants
Start Date
April 10, 2015
Primary Completion Date
December 12, 2020
Study Completion Date
June 1, 2021
Romiplostim
Romiplostim at the assigned dose will be administered subcutaneously (SQ) once a week for 6 weeks. The dose will be assigned at the time of subject registration. This is a dose escalation to determine the maximum tolerated dose. The doses include 4 mcg/kg/dose, 6 mcg/kg/dose, 8 mcg/kg/dose, and 10 mcg/kg/dose.
University of Minnesota Masonic Cancer Center, Minneapolis
Masonic Cancer Center, University of Minnesota
OTHER